BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3350115)

  • 1. A pyruvate kinase variant in different mouse transplanted tumors.
    Marchut E; Gumińska M; Kedryna T; Radzikowski C; Kuśnierczyk H
    Experientia; 1988 Jan; 44(1):25-7. PubMed ID: 3350115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate kinase from cytosolic fractions of the Ehrlich ascites tumour, normal mouse liver and skeletal muscle.
    Kedryna T; Gumińska M; Marchut E
    Biochim Biophys Acta; 1990 May; 1039(1):130-3. PubMed ID: 2354196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase isoenzymes in chromatin extracts of Ehrlich ascites tumour, Morris hepatoma 7777 and normal mouse and rat livers.
    Gumińska M; Stachurska MB; Ignacak J
    Biochim Biophys Acta; 1988 Aug; 966(2):207-13. PubMed ID: 3401505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deviation of isozyme pattern of pyruvate kinase in the liver of nude mice bearing allogeneic or xenogeneic tumor.
    Kashiwagi A; Fujita M; Usugane M; Taguchi T; Tanaka T
    Gan; 1978 Feb; 69(1):127-31. PubMed ID: 640321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
    Gumińska M; Ignacak J; Kedryna T; Stachurska MB
    Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor responsible for the metabolic deviations in liver of tumor-bearing animals.
    Tanaka T; Yanagi S; Miyahara M; Kaku R; Imamura K
    Gan; 1972 Oct; 63(5):555-62. PubMed ID: 4645275
    [No Abstract]   [Full Text] [Related]  

  • 7. An allele (Pk-1b) from wild-caught mice that affects the activity and kinetics of erythrocyte and liver pyruvate kinase.
    Moore KJ; Bulfield G
    Biochem Genet; 1981 Aug; 19(7-8):771-81. PubMed ID: 7295298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of ammonium and potassium ions on pyruvate kinase from Ehrlich ascites tumor cells.
    Olavarría JS; Artacho E; Sánchez F; Martínez P; Núñez de Castro I
    Enzyme; 1986; 35(1):34-41. PubMed ID: 3732223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic pattern of cytosolic pyruvate kinase fractions A and B (type L and M2) from normal rat liver and Morris hepatoma 7777.
    Gumińska M; Ignacak J
    Biochim Biophys Acta; 1996 Jan; 1292(1):99-105. PubMed ID: 8547355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells.
    Marchut E; Gumińska M; Kedryna T
    Acta Biochim Pol; 1986; 33(1):7-16. PubMed ID: 2940781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isozymes in the liver from mice given hepatocarcinogen and from tumor-bearing mice.
    Yanagi S; Kamiya T; Ikehara Y; Endo H
    Gan; 1971 Aug; 62(4):283-91. PubMed ID: 5094167
    [No Abstract]   [Full Text] [Related]  

  • 12. Extraction of a factor from Ehrlich ascites tumor cells that increases the activity of the fetal isozyme of pyruvate kinase in mouse liver.
    Ibsen KH; Basabe JR; Lopez TP
    Cancer Res; 1975 Jan; 35(1):180-8. PubMed ID: 1109787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pyruvate kinase variants from rat liver and Morris hepatoma 7777, obtained by an affinity chromatography on blue sepharose CL-6B.
    Ignacak J; Gumińska M
    Acta Biochim Pol; 1993; 40(2):261-7. PubMed ID: 8212964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines.
    Gumińska M; Stachurska MB; Christensen B; Tromholt V; Kieler J; Radzikowski C; Duś D
    Experientia; 1989 Jun; 45(6):571-4. PubMed ID: 2737264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of L-cysteine and its derivatives on glycolysis in Ehrlich ascites tumour cells.
    Kedryna T; Gumińska M; Marchut E
    Biochim Biophys Acta; 1983 Aug; 763(1):64-71. PubMed ID: 6871258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of tumor-cell respiration by inhibitors of pyruvate kinase.
    Gosalvez M; López-Alarcón L; García-Suarez S; Montalvo A; Weinhouse S
    Eur J Biochem; 1975 Jun; 55(1):315-21. PubMed ID: 1175605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control mechanisms of oxygen and glucose utilization in tumours.
    Gosalvez M; Weinhouse S
    Adv Exp Med Biol; 1976; 75():587-96. PubMed ID: 1035033
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of levamisole on energy metabolism in Ehrlich ascites tumour cells in vitro.
    Gumińska M; Kedryna T; Marchut E
    Biochem Pharmacol; 1986 Dec; 35(24):4369-74. PubMed ID: 2947578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-dependent RNA polymerases of Ehrlich carcinoma, other murine ascites tumors, and murine normal tissues.
    Blair DG
    J Natl Cancer Inst; 1975 Aug; 55(2):397-412. PubMed ID: 1174142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
    Castillo R; Díaz JW; Veloso A; Gavilondo J
    Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.